国际生殖健康/计划生育 ›› 2013, Vol. 32 ›› Issue (2): 107-110.

• 综述 • 上一篇    下一篇

皮下埋植避孕剂的研究进展

钱翠凤,黄紫蓉   

  1. 200011 上海,复旦大学附属妇产科医院
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2013-03-15 发布日期:2013-03-15
  • 通讯作者: 黄紫蓉

Advance in the Subdermal Contraceptive Implants

QIAN Cui-feng,HUANG Zi-rong   

  1. Obstetrics and Gynecology Hospital of Fudan University,Shanghai 200011,China
  • Received:1900-01-01 Revised:1900-01-01 Published:2013-03-15 Online:2013-03-15
  • Contact: HUANG Zi-rong

摘要: 皮下埋植避孕剂释放单纯孕激素,是育龄期妇女常用的避孕方法之一,也是有效、长效和安全的避孕方法。皮下埋植剂的发展经历了缓释系统的改进和孕激素种类的优化,适用于多数妇女。月经异常是其最常见的不良反应,而其他不良反应发生率低,且多在使用过程中逐渐减轻,严重不良反应罕见。但皮下埋植避孕剂的植入和取出需专业人员进行以及月经改变仍是制约其发展的重要因素。近年的研究主要集中于其不良反应和安全性问题,其对代谢、骨密度、乳汁和婴儿等的影响仍需进一步研究。如何减少不良反应和研发可降解的皮下埋植剂是尚待解决的问题。

关键词: 避孕药, 孕激素类, 埋藏疗法, 有效性研究

Abstract: The progestogen-releasing subdermal implants were popular contraceptive methods for those reproductive age women because of their effectiveness,long-duration and safety. The implants were suitable for most women with the improved releasing system and optimized progestogen. Unscheduled bleeding was the most common adverse event while other adverse events rarely occured. All adverse events will gradually alleviate, without any serious adverse events. It is disadvantage that implants must be inserted and removed by a surgical professional. Resent studies concentrated on the safety and adverse events of implants, including their influences on metabolism, bone mineral density, breast milk and infants, etc. At present, two main problems are how to reduce adverse events and to develop new biodegradable implants.

Key words: Contraceptive agents, Progestins, Embedding therapy, Validation studies